Advanced medical diagnostics
The evolving diagnostics industry in Australia is facilitating a shift from managing chronic diseases as they arise to detecting them well before they've had a chance to take hold. We're developing solutions to detect and prevent chronic diseases like cancer, Alzheimer’s disease and metabolic diseases from occurring.
Bioconjugates and theranostics
CSIRO offers the full spectrum of bioconjugation services to couple diverse targeting biomolecules.
Our researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.
Biomedical devices encompass a large range of products from bandages to complex, life-saving implantable devices and for imaging, health monitoring and diagnostics.
Biosensors and diagnostics
Biosensors and diagnostics are becoming increasingly integral for patient healthcare. They not only aid in the detection and monitoring of disease but also play a vital role in managing overall health.
Botanical and psychoactive therapeutics
CSIRO supports early-stage drug discovery, focussing on target biology, synthetic and medicinal chemistry, in vitro and in vivo testing and process development for up-scale manufacturing.
CSIRO offers world-class clinical trial capability spanning nutrition research, health diagnostics and vaccines.
Our unique expertise works to minimise the impact of costly infectious disease outbreaks.
Medtech to market
CSIRO's Biomedical Materials Translational Facility (BMTF) helps medtech companies turn new discoveries into market ready products.
With our specialist knowledge of how foods, extracts and nutrients impact gut, cardio-metabolic and brain health, we can develop and scientifically substantiate nutrition solutions resulting in health and economic benefits for Australians.